976519781
The Markets

Ebos drags NZX50 higher as healthcare stocks find favour

Wednesday 22nd of December 2021

The benchmark index edged up 8.35 points, or 0.1%, to 12,865.22 in relatively modest trading, with turnover across the entire market of $111.5 million.

Ebos rose 3.8% to $39.17 and is up 40.4% so far this year as investors continue to laud the animal and healthcare products manufacturer’s nous for acquisitions. Ebos is finishing off the retail component of raising A$742m (NZ$784m) to help fund its $1.17 billion acquisition of medical products distributor LifeHealthcare.

“If you go back to the start of the year, a lot of brokers would have said that 2021 will be Ebos’s year,” said Peter McIntyre, an investment adviser at Craigs Investment Partners. “This is fulfilling the promise.”

Other healthcare stocks also found favour today, with AFT Pharmaceuticals up 4.4% at $4.49, Blis Technologies advancing 4.2% to 5 cents and, tangentially, Comvita rising 0.3% to $3.55.

Want to read the full article?

Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.

You will also be able to comment on articles on Good Returns.